Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Leon-Nanodrugs Appoints CEO

This article was originally published in Scrip

Executive Summary

Leon-Nanodrugs, a nanotechnology-based drug development company, has named Theron Odlaug CEO of Leon-Nanodrugs GmbH. in Germany and Leon-Nanodrugs, Inc in the US. Odlaug has more than 35 years of experience in the biopharmaceutical industry and joins Leon-Nanodrugs from Cedarburg Pharmaceuticals where he was executive chair. Previously, he was the executive chair and CEO of Planet Biopharmaceuticals and CEO of CyDex Pharmaceuticals, Inc.

Advertisement

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register